Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
暂无分享，去创建一个
M. Hallek | A. Chanan-Khan | A. Howes | N. Bartlett | G. Fraser | A. Goy | A. Mato | S. Rule | O. Samoilova | M. Dilhuydy | J. Mayer | D. Villa | P. Cramer | A. Avigdor | F. Demirkan | A. Janssens | Rodrigo Santucci Silva | S. Balasubramanian | M. Pavlovsky | C. Phelps | H. Pylypenko | S. Grosicki | Steven Sun | J. Loscertales | R. S. Silva | A. Pristupa | P. Panagiotidis | C. Karlsson | M. Mahler | M. Salman